C-reactive protein levels, indicative of inflammation, were significantly higher in the T1D (27.4 mg/L) and T2D (38.2 mg/L) groups compared to the no diabetes group (15.2 mg/L), suggesting more pronounced inflammatory responses in patients with diabetes (p < 0.001). The gene discussed is CRP; the disease is type 2 diabetes mellitus.